Sustained Release Fluocinolone Acetonide for Uveitis

Dilraj Grewal, MD

Show Description +

Dilraj Grewal, MD, discusses a post hoc analysis that sought to understand the true recurrence rates of noninfectious uveitis in eyes treated with a fluocinolone acetonide implant. Dr. Grewal explains how arriving at a true recurrence rate requires accounting for use of systemic medications that may affect disease control.

Posted: 8/03/2020

Keywords:

fluocinolone acetonide implant

•

Uveitis

Up Next

Name: Sustained Release Fluocinolone Acetonide for Uveitis
Uploaded: 2020-08-03T14:18:00+00:00
Description: Dilraj Grewal, MD, discusses a post hoc analysis that sought to understand the true recurrence rates of noninfectious uveitis in eyes treated with a fluocinolone acetonide implant. Dr. Grewal explains how arriving at a true recurrence rate requires accounting for use of systemic medications that may affect disease control.